• VIDEO: Avicenna Alliance
    at the European Parliament

    At the invitation of the European Parliament, Avicenna Alliance's leaders supported by senior people from FDA, ANSYS, Medtronic, CIPLA, VPHi, EFGCP and RPP, have explained to delegations from Europe, USA, India and Japan the central role played by in silico healthcare to accelerate medical innovation.

    View the video!

Avicenna Alliance news

Quantum technologies are getting momentum in the EU

On February 27 Austria, Bulgaria, Denmark and Romania have agreed to work together with 20 other EU Member States towards the development of a...

find out more ›

The Avicenna Alliance answers the consultation for Europe’s Beating Cancer Plan

On 3 March 2020, the Avicenna Alliance has submitted feedback on the roadmap of Europe’s Beating Cancer Plan. With...

find out more ›

European Commission's Data Strategy mentions benefits of CM&S and digital twins

On 19 February, the European Commission has released a communication addressing the European strategy for data which...

find out more ›

Show all activites

Avicenna Alliance the Association for Predictive Medicine

The Avicenna Alliance, is an association of industry and renowned academia/healthcare organizations who have a commercial or research interest in the development of in silico medicine. The Association, established in 2015, has its origins in the Virtual Physiological Human Initiative, a European Commission endorsed research area on computer modeling and simulation. Tasked by the European Commission with developing a “Roadmap for in silico medicine”, the Association now seeks to put this roadmap into policy and ensure the development of a regulated in silico market.

This Association bridges the gap between the scientific community, industry and policy makers by advocating for policy changes that take into account scientific and market developments.

read more

Avicenna Alliance: 
enhanced knowledge, improved decisions, better outcomes

Sign up for our monthly newsletter!


Sign up